PDL BioPharma, Inc. Variable Interest Entity, Reporting Entity Involvement, Maximum Loss Exposure, Amount
PDL BioPharma, Inc. had Variable Interest Entity, Reporting Entity Involvement, Maximum Loss Exposure, Amount of $223.70 million as of 2014-03-31, per its 10-Q filed 2014-05-12.
Discontinued › Notes › Consolidation and Presentation of Financial Statements
us-gaap:VariableInterestEntityEntityMaximumLossExposureAmount · last filed 2014-05-12
- 2014-03-31: Variable Interest Entity, Reporting Entity Involvement, Maximum Loss Exposure, Amount $223.70M.
- 2013-12-31: Variable Interest Entity, Reporting Entity Involvement, Maximum Loss Exposure, Amount $235.70M.
| Period end | Variable Interest Entity, Reporting Entity Involvement, Maximum Loss Exposure, Amount |
|---|---|
| 2014-03-31 | $223.70M 10-Q · filed 2014-05-12 |
| 2013-12-31 | $235.70M 10-K · filed 2014-03-03 |